Results 101 to 110 of about 921 (218)
ABSTRACT Biologics and Janus kinase (JAK) inhibitors have transformed the management of atopic dermatitis (AD), yet some patients experience early worsening of disease activity during treatment initiation. In clinical trials, these events are typically recorded as treatment‐emergent adverse events (TEAEs), most commonly coded as “atopic dermatitis”. We
Diego Ruiz Dasilva +17 more
wiley +1 more source
Intra-articular glucocorticoid injections for knee osteoarthritis. [PDF]
Du J, Hawker G, King LK.
europepmc +1 more source
ABSTRACT Emollients and cleansers are essential components in managing atopic dermatitis (AD). While international evidence‐based guidelines recommend using gentle cleansers and emollients daily as a foundational therapy for AD, implementation in practice remains suboptimal.
Mette Deleuran +12 more
wiley +1 more source
Propagating slow-mode shocks discovered in dynamical solar flare loops. [PDF]
Ye J +8 more
europepmc +1 more source
ABSTRACT Background Subcorneal pustular dermatosis (SPD), or Sneddon–Wilkinson disease, is a rare, relapsing pustular skin condition of unknown cause, characterised by subcorneal pustules. Objectives To summarise the demographic, clinical, histopathological, management and disease course of SPD.
Mason H. Crossman +5 more
wiley +1 more source
Coronal dimmings and what they tell us about solar and stellar coronal mass ejections. [PDF]
Veronig AM +12 more
europepmc +1 more source
Nail Psoriasis in Pediatric Populations
ABSTRACT Pediatric nail psoriasis is an under‐recognized yet clinically important manifestation of psoriasis with both diagnostic and prognostic implications. Nail involvement in children is associated with greater overall disease severity, poorer treatment outcomes, and is a predictor for the development of psoriatic arthritis.
Aditya K. Gupta +3 more
wiley +1 more source
Wearable devices detect physiological changes that precede and are associated with symptomatic and inflammatory rheumatoid arthritis flares. [PDF]
Sharma P +8 more
europepmc +1 more source
Real World Use of the IL‐36 Receptor Antagonist Spesolimab: A Systematic Review and Analysis
ABSTRACT Background Spesolimab, an interleukin‐36 receptor antagonist, is approved for the treatment and prevention of generalised pustular psoriasis (GPP) flares. Its use has increasingly been reported in real‐world settings for both GPP and other inflammatory dermatoses.
Sophia A. Mense +4 more
wiley +1 more source
A tidal disruption event from an intermediate-mass black hole revealed by comprehensive multi-wavelength observations. [PDF]
Wang J +14 more
europepmc +1 more source

